Novel Anticoagulant Treatment for Pulmonary Embolism With Direct Oral Anticoagulants Phase 3 Trials and Clinical Practice

Seminars in Interventional Radiology - United States
doi 10.1055/s-0038-1642622
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

New Oral Anticoagulants in the Treatment of Pulmonary Embolism: Efficacy, Bleeding Risk, and Monitoring

Thrombosis
Cardiovascular MedicineHematologyCardiology
2013English

Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2008English

Reversal of Direct Oral Anticoagulants in Hemophilia Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Laboratory Tests During Direct Oral Anticoagulant Treatment? No

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2013English

Direct Oral Anticoagulants (DOACs)

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Thrombolytic and Anticoagulant Therapy for Acute Submassive Pulmonary Embolism

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

MRI Analysis From Two Phase 3 Randomized Clinical Trials; Treatment of Symptomatic Knee Osteoarthritis With Oral Salmon Calcitonin

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

Direct Oral Anticoagulants in Patients With Thrombophilia: Challenges in Diagnostic Evaluation and Treatment

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Novel Oral Anticoagulants and Risk

Clinical Oral Implants Research
Oral Surgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy